Challenges and Revisions in Diagnostic Criteria: Advancing Early Detection of Prion Diseases. [PDF]
Shimamura MI, Satoh K.
europepmc +1 more source
Reactive astrocytes in prion diseases: Friend or foe? [PDF]
Makarava N, Kushwaha R, Baskakov IV.
europepmc +1 more source
Downregulation of STAT3 transcription factor reverses synaptotoxic phenotype of reactive astrocytes associated with prion diseases. [PDF]
Kushwaha R +3 more
europepmc +1 more source
Post-translational modifications in prion diseases. [PDF]
Bizingre C +5 more
europepmc +1 more source
Abnormal Expression of Proteolytic Stress-Related Proteins and Protective Effect of Fibrinolytic Enzymes in Prion Diseases. [PDF]
Kim YC, Won SY, Jeong BH.
europepmc +1 more source
Reactive microglia partially envelop viable neurons in prion diseases. [PDF]
Makarava N +9 more
europepmc +1 more source
Prion diseases disrupt glutamate/glutamine metabolism in skeletal muscle. [PDF]
Caredio D +13 more
europepmc +1 more source
Irisin regulates oxidative stress and mitochondrial dysfunction through the UCP2-AMPK pathway in prion diseases. [PDF]
Wen P +11 more
europepmc +1 more source
β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease. [PDF]
Xu B +11 more
europepmc +1 more source

